Tevogen Inc.
TVGN- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001860871
No open-market purchases or sales by Tevogen Inc. insiders were filed in the last 90 days; 30 institutions reported holding it in 13F filings for Q2 2026, worth $607.7K in total; no superinvestor holds it.
Other share classesTVGNW
13F holders, Q2 2024
Institutional positions in Tevogen Inc. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 27
- +22 vs. Q1 2024
- Shares held
- 5.68M
- −1.10M (−16.2%) vs. Q1 2024
- Total value
- $2.89M
- −$27.8M (−90.6%) vs. Q1 2024
- New holders
- 23
- 2 more added
- Sold out
- 1
- 1 more reduced
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TVGN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 30 | $607.7K |
| Q1 2026 | 30 | $614.1K |
| Q4 2025 | 51 | $1.68M |
| Q3 2025 | 52 | $3.78M |
| Q2 2025 | 55 | $6.04M |
| Q1 2025 | 51 | $4.16M |
| Q4 2024 | 44 | $2.49M |
| Q3 2024 | 35 | $2.08M |
| Q2 2024 | 27 | $2.89M |
| Q1 2024 | 5 | $30.7M |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding Tevogen Inc.; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Amalgamated Bank | 757 | $1.00K | 0.00% | +757 | New |
| Royal Bank of Canada | 2,058 | $1.00K | 0.00% | +2,058 | New |
| BNP Paribas Arbitrage, SA | 1,574 | $1.14K | 0.00% | +1,574 | New |
| California State Teachers Retirement System | 1,585 | $1.15K | 0.00% | +1,585 | New |
| Ameritas Investment Partners, Inc. | 2,143 | $1.55K | 0.00% | +2,143 | New |
| Citigroup Inc | 4,826 | $3.49K | 0.00% | +4,826 | New |
| UBS Group AG | 6,639 | $4.80K | 0.00% | +6,639 | New |
| Barclays PLC | 7,521 | $5.44K | 0.00% | +7,521 | New |
| Wells Fargo & Company | 8,142 | $5.89K | 0.00% | +8,142 | New |
| JPMorgan Chase & Co | 9,324 | $6.74K | 0.00% | +9,294+30,980.0% | Added |
| Invesco Ltd. | 10,273 | $7.43K | 0.00% | +10,273 | New |
| Bank of America Corp | 11,004 | $7.96K | 0.00% | +11,004 | New |
| Two Sigma Securities, LLC | 11,410 | $8.25K | 0.00% | +11,410 | New |
| Corebridge Financial, Inc. | 11,771 | $8.63K | 0.00% | +11,771 | New |
| Rhumbline Advisers | 19,766 | $14.3K | 0.00% | +19,766 | New |
| Morgan Stanley | 20,698 | $15.0K | 0.00% | +20,698 | New |
| Alpine Global Management, LLC | 21,044 | $15.2K | 0.00% | +21,044 | New |
| Citadel Advisors LLC | 48,398 | $35.0K | 0.00% | +48,398 | New |
| Charles Schwab Investment Management Inc | 49,581 | $35.9K | 0.00% | +49,581 | New |
| State Street Corp | 64,534 | $46.7K | 0.00% | +64,534 | New |
| Vanguard Group Inc | 133,860 | $96.8K | 0.00% | +133,860 | New |
| New York State Common Retirement Fund | 137,000 | $99.1K | 0.00% | +137,000 | New |
| BlackRock Inc. | 212,872 | $153.9K | 0.00% | +212,872 | New |
| Polar Asset Management Partners Inc. | 1,985,615 | $213.9K | 0.01% | +1,651,000+493.4% | Added |
| Geode Capital Management, LLC | 340,802 | $246.5K | 0.00% | +340,802 | New |
| Cantor Fitzgerald, L. P. | 650,000 | $470.1K | 0.09% | 00.0% | Unchanged |
| Portland Global Advisors LLC | 1,910,517 | $1.38M | 0.19% | −3,871,692−67.0% | Reduced |
| HRT Financial LP | 0 | $0 | 0.00% | −12,278−100.0% | Sold out |